Applied DNA Earnings Estimate

APDN Stock  USD 0.18  0.00  0.000006%   
By analyzing Applied DNA's earnings estimates, investors can diagnose different trends across Applied DNA's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Applied DNA Sciences is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Credit Downgrade
 
Yuan Drop
 
Covid
Applied DNA is projected to generate -0.33 in earnings per share on the 31st of December 2024. Applied DNA earnings estimates show analyst consensus about projected Applied DNA Sciences EPS (Earning Per Share). It derives the highest and the lowest estimates based on Applied DNA's historical volatility. Many public companies, such as Applied DNA, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Applied DNA's earnings estimates, investors can diagnose different trends across Applied DNA's analyst sentiment over time as well as compare current estimates against different timeframes. As of the 1st of February 2025, Gross Profit is likely to drop to about 1.1 M. In addition to that, Pretax Profit Margin is likely to drop to -1.95
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Applied DNA Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

Applied DNA Earnings per Share Projection vs Actual

About Applied DNA Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Applied DNA earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Applied DNA estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Applied DNA fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-278.7 M-264.8 M
Retained Earnings Total Equity-242.9 M-255 M
Price Earnings Ratio(791.29)(751.73)
Price Earnings To Growth Ratio 8.57  9.00 

Pair Trading with Applied DNA

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Applied DNA position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Applied DNA will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Applied DNA could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Applied DNA when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Applied DNA - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Applied DNA Sciences to buy it.
The correlation of Applied DNA is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Applied DNA moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Applied DNA Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Applied DNA can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Applied DNA Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Applied DNA's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Applied Dna Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Applied Dna Sciences Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Applied DNA Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Electronic Equipment, Instruments & Components space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Applied DNA. If investors know Applied will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Applied DNA listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.82)
Revenue Per Share
2.202
Quarterly Revenue Growth
(0.73)
Return On Assets
(0.57)
Return On Equity
(0.76)
The market value of Applied DNA Sciences is measured differently than its book value, which is the value of Applied that is recorded on the company's balance sheet. Investors also form their own opinion of Applied DNA's value that differs from its market value or its book value, called intrinsic value, which is Applied DNA's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Applied DNA's market value can be influenced by many factors that don't directly affect Applied DNA's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Applied DNA's value and its price as these two are different measures arrived at by different means. Investors typically determine if Applied DNA is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Applied DNA's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.